Pyxis Oncology, Inc. (PYXS) Financials

PYXS Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 186.7 million 48.7 million
2023-06-30 175.2 million 30.0 million
2023-03-31 182.8 million 30.6 million
2022-12-31 211.4 million 50.6 million

PYXS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -17.6 million 5.2 million
2023-06-30 -13.3 million 3.7 million
2023-03-31 -31.2 million 4.9 million
2022-12-31 -19.2 million 3.9 million

PYXS Net Income

No data available :(

PYXS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 133.0 million - 21.6 million
2023-06-30 142.7 million - 21.3 million
2023-03-31 149.3 million - 20.3 million
2022-12-31 179.3 million - 18.9 million

PYXS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 41.3 million
2023-06-30 38.4 million
2023-03-31 35.4 million
2022-12-31 33.0 million

PYXS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 61000 14.7 million 10.7 million -
2023-06-30 2.3 million 11.4 million 6.7 million -
2023-03-31 4.4 million 11.9 million 9.1 million -
2022-12-31 1.9 million 29.9 million 8.1 million -

PYXS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 677000
2023-06-30 - 699000
2023-03-31 - 334000
2022-12-31 - 464000

PYXS

Price: $4.31

52 week price:
1.35
6.85

Earnings Per Share: -1.85 USD

P/E Ratio: -2.10

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 10300

Market Capitalization: 272.6 million

Links: